Increase/Decrease in Cash: The total change in cash for the company over the given period.
Milestone Pharmaceuticals Inc. (MIST) had Increase/Decrease in Cash of $96.68M for the most recently reported fiscal quarter, ending 2026-06-30.
| Income Statement Financials | |
$0.56M |
|
$-28.61M |
|
$0.03M |
|
$0.53M |
|
$26.19M |
|
$-25.63M |
|
$-2.98M |
|
$-28.61M |
|
$-28.61M |
|
$-28.61M |
|
$-28.61M |
|
$-28.61M |
|
$-28.61M |
|
$-25.63M |
|
$-25.57M |
|
138.69M |
|
138.69M |
|
$-0.21 |
|
$-0.21 |
|
| Balance Sheet Financials | |
$180.33M |
|
$0.47M |
|
$1.30M |
|
$181.62M |
|
$22.18M |
|
$59.21M |
|
$141.22M |
|
$163.41M |
|
$18.22M |
|
$18.22M |
|
$18.22M |
|
124.50M |
|
| Cash Flow Statement Financials | |
$-38.77M |
|
$31.96M |
|
$103.49M |
|
$73.05M |
|
$169.73M |
|
|
Increase/Decrease in Cash |
$96.68M |
$2.62M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
8.13 |
|
-- |
|
-- |
|
0.76 |
|
3.25 |
|
94.28% |
|
-4584.97% |
|
-4584.97% |
|
-- |
|
-5118.78% |
|
-5118.78% |
|
$-38.84M |
|
-- |
|
-- |
|
-- |
|
0.00 |
|
0.01 |
|
0.16 |
|
554.81 |
|
-157.06% |
|
-157.06% |
|
-15.75% |
|
-36.96% |
|
$0.15 |
|
$-0.28 |
|
$-0.28 |
|